Name: | Description: | Size: | Format: | |
---|---|---|---|---|
2.58 MB | Adobe PDF |
Advisor(s)
Abstract(s)
The efficiency of photodynamic therapy is limited mainly due to low selectivity, unfavorable
biodistribution of photosensitizers, and long-lasting skin sensitivity to light. However, drug delivery
systems based on nanoparticles may overcome the limitations mentioned above. Among others,
dendrimers are particularly attractive as carriers, because of their globular architecture and high
loading capacity. The goal of the study was to check whether an anionic phosphorus dendrimer is
suitable as a carrier of a photosensitizer—methylene blue (MB). As a biological model, basal cell
carcinoma cell lines were used. We checked the influence of the MB complexation on its singlet
oxygen production ability using a commercial fluorescence probe. Next, cellular uptake, phototoxicity,
reactive oxygen species (ROS) generation, and cell death were investigated. The MB-anionic
dendrimer complex (MB-1an) was found to generate less singlet oxygen; however, the complex
showed higher cellular uptake and phototoxicity against basal cell carcinoma cell lines, which was
accompanied with enhanced ROS production. Owing to the obtained results, we conclude that the
photodynamic activity of MB complexed with an anionic dendrimer is higher than free MB against
basal cell carcinoma cell lines.
Description
Keywords
Methylene blue Phosphorus dendrimer Nanocarrier Photosensitizer Photodynamic therapy Phototoxicity Basal cell carcinoma . Faculdade de Ciências Exatas e da Engenharia
Citation
Dabrzalska, M., Janaszewska, A., Zablocka, M., Mignani, S., Majoral, J. P., & Klajnert-Maculewicz, B. (2017). Complexing methylene blue with phosphorus dendrimers to increase photodynamic activity. Molecules, 22(3), 345.
Publisher
MDPI